Literature DB >> 29476579

Reporting the incidence of unplanned extubation in the neonatal intensive care unit.

Laurene Aydon1,2,3, Margo Zimmer1,2, Mary Sharp1,3.   

Abstract

AIM: The aim of this study was to highlight the incidence of unplanned extubation (UE) and identify associated factors in our neonatal population.
METHODS: This study was a prospective audit.
RESULTS: A specifically designed audit tool was used to capture UE events; 182 neonates required mechanical ventilation for 863 days. There were 41 episodes of UE. The UE rate was 4.75 per 100 days of ventilation. At the time of UE, median gestational age of patients was 27.3 weeks (23.4-37.6), with a corrected age median of 29.2 weeks (23.4-37.6). Re-intubation was required in two thirds of the patients for increasing apnoea and increased work of breathing. Endotracheal tubes are secured in a standardised way either using Neobar or brown tape. UE events occurred with both methods. The two most common factors associated with UE included active handling of the baby and the time of day (0700-1000 h).
CONCLUSIONS: This audit has provided our neonatal intensive care unit with a benchmark for improvement. It has also created staff awareness of the risk of UE and promoted staff engagement to reduce UE. A bundle approach to reduce UE has been introduced. Future audits are planned to monitor the impact of these initiatives.
© 2018 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  endotracheal tube; quality improvement; unplanned extubation

Mesh:

Year:  2018        PMID: 29476579     DOI: 10.1111/jpc.13850

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  1 in total

1.  The application of standardized nursing assessment and intervention in reducing the incidence of unplanned extubation of gastric tube.

Authors:  Dandan Liu; Dan Zhao; Zaiping Luo; Ling Jin; Li Ding
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.